Key regions: Brazil, India, United Kingdom, Germany, China
The Digestives & Intestinal Remedies market in Central & Western Europe has been experiencing steady growth in recent years, driven by a combination of changing customer preferences, market trends, and local special circumstances. Customer preferences in the region have shifted towards natural and organic products, as consumers become more health-conscious and seek out remedies that are perceived to be safer and more sustainable. This has led to an increased demand for digestive and intestinal remedies that are made from natural ingredients and free from artificial additives. Additionally, there is a growing interest in probiotic products, as consumers recognize the importance of maintaining a healthy gut microbiome for overall well-being. Trends in the market include the rise of e-commerce and online retail platforms, which have made it easier for consumers to access a wide range of digestive and intestinal remedies. This has also allowed smaller, niche brands to enter the market and cater to specific consumer needs. Furthermore, there has been an increased focus on product innovation and differentiation, with companies introducing new formulations and delivery formats to attract customers. For example, there has been a growing trend towards chewable tablets and gummies, which are seen as more convenient and enjoyable to consume. Local special circumstances in Central & Western Europe also play a role in shaping the market. For instance, the region has a large aging population, which is more prone to digestive issues and therefore has a higher demand for digestive and intestinal remedies. Additionally, the prevalence of certain dietary habits, such as the consumption of rich and heavy foods, can contribute to digestive problems and drive the need for remedies. Underlying macroeconomic factors, such as the overall economic stability and disposable income levels in the region, also influence the development of the Digestives & Intestinal Remedies market. As the economy improves and consumers have more spending power, they are more likely to invest in their health and purchase remedies to alleviate digestive discomfort. Furthermore, the growing awareness and acceptance of alternative medicine and natural remedies in the region have contributed to the market growth. In conclusion, the Digestives & Intestinal Remedies market in Central & Western Europe is experiencing growth due to changing customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural and organic products, the rise of e-commerce, and the focus on product innovation are key drivers of this growth. The aging population and dietary habits in the region also contribute to the demand for digestive and intestinal remedies. Overall, the market is expected to continue expanding as consumers prioritize their digestive health and seek out effective and convenient remedies.
Data coverage:
Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
